Skip to content

Using Pedometers for the Assessment and Enhancement of Mobility in Gynaecological and Oncological Patients Following Surgery.

Using Pedometers for the Assessment and Enhancement of Mobility in Gynaecological and Oncological Patients Following Surgery.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04711421
Enrollment
150
Registered
2021-01-15
Start date
2020-05-01
Completion date
2022-05-01
Last updated
2021-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Cancer, Mobilization, Surgery

Brief summary

This is a prospective cohort study, planned to study the effects of pedometers (digital step counters) on patient mobility following gynecology and gynecology oncology surgeries. The investigators plan to study the effect of personalized repeated feedback approach based on pedometer results in patients following gynecology and gynecology oncology surgeries.

Interventions

DEVICE4 VIVOFIT-

Feedback on number of steps taken by patint, as recorded by pedometers, provided by research team

Sponsors

Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

Patients following gynecology and gynecology oncology surgery Consent to participation No medical recommendation for bed rest and limited mobility

Exclusion criteria

Refusal to participate Medical recommendation to limit mobility

Design outcomes

Primary

MeasureTime frameDescription
Number of steps per day during the hospitalization periodUp to 1 weekumber of steps taken by patient as recirded by pedometer

Secondary

MeasureTime frameDescription
Number of participants with complication following surgeryUp to 1 weekinfectious ( wound), blood product transfusion
Number of analgesic dosesUp to 1 weekNumber of doses of analgesics consumed by patient
Length of hospitalizationUp to 4 weekDuration of hospitalization following surgery
Number of thromboembolic eventsUp to 4 weekhromboembolic events, including deep vein thrombosis and pulmonary emboli

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026